Home treatment with subcutaneous immunoglobulin infusion to children with primary immunodeficiency disease; the role of the nurse

被引:0
作者
Halvorsen, K. [1 ]
Sandersen, H. [1 ]
Lynum, M. B. [1 ]
Abrahamsen, T. G. [1 ,2 ]
机构
[1] Rikshosp Univ Hosp, Div Paediat, Oslo, Norway
[2] Univ Oslo, Oslo, Norway
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:23 / 23
页数:1
相关论文
共 50 条
  • [31] Efficacy and Safety of Hospital-Based Intravenous Immunoglobulin and Home-Based Self-Administered Subcutaneous Immunoglobulin in Polish Children with Primary Immunodeficiency Diseases
    Katarzyna Bal
    Izabela Kałuzińska-Parzyszek
    Agnieszka Sobocińska
    Daniela Podlecka
    Joanna Jerzyńska
    Iwona Stelmach
    The Indian Journal of Pediatrics, 2015, 82 : 768 - 769
  • [32] THYMOSIN TREATMENT OF CHILDREN WITH PRIMARY IMMUNODEFICIENCY DISEASE
    WARA, DW
    AMMANN, AJ
    TRANSPLANTATION PROCEEDINGS, 1978, 10 (01) : 203 - 209
  • [33] Efficacy and Safety of Hospital-Based Intravenous Immunoglobulin and Home-Based Self-Administered Subcutaneous Immunoglobulin in Polish Children with Primary Immunodeficiency Diseases
    Bal, Katarzyna
    Kaluzinska-Parzyszek, Izabela
    Sobocinska, Agnieszka
    Podlecka, Daniela
    Jerzynska, Joanna
    Stelmach, Iwona
    INDIAN JOURNAL OF PEDIATRICS, 2015, 82 (08) : 768 - 769
  • [34] Subcutaneous immunoglobulin infusion in patient with primary antibody deficiency: A safe and cheaper form of treatment
    Neto, AP
    Scheneider, D
    Bittencourt, R
    Silveira, V
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S215 - S215
  • [35] Evaluating Dose Ratio of Subcutaneous to Intravenous Immunoglobulin Therapy Among Patients With Primary Immunodeficiency Disease Switching to 20% Subcutaneous Immunoglobulin Therapy
    Krishnarajah, Girishanthy
    Lehmann, Jee-Yeon K.
    Ellman, Brian
    Bhak, Rachel H.
    DerSarkissian, Maral
    Leader, Deane, Jr.
    Bullinger, Ann L.
    Duh, Mei Sheng
    AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (15) : S475 - S481
  • [36] Safety and Efficacy of Home-Based Subcutaneous Immunoglobulin G in Elderly Patients with Primary Immunodeficiency Diseases
    Stein, Mark R.
    Koterba, Alan
    Rodden, Linda
    Berger, Melvin
    POSTGRADUATE MEDICINE, 2011, 123 (05) : 186 - 193
  • [37] Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin home therapy in a patient with primary immunodeficiency
    Knight, Emma
    Carne, Emily
    Novak, Barbara
    El-Shanawany, Tariq
    Williams, Paul
    Pickersgill, Trevor
    Jolles, Stephen
    JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (09) : 846 - 847
  • [38] CSL BEHRING CARES: SUPPORTING PATIENTS WITH PRIMARY IMMUNODEFICIENCY (PID) TO USE SUBCUTANEOUS IMMUNOGLOBULIN (HIZENTRA®) IN THE HOME
    Tognarini, David
    Fenton, Kathryn
    Kim, Emilia
    Youssef, Sherif
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 30 - 31
  • [39] Subcutaneous immunoglobulin (16 or 20%) therapy in obese patients with primary immunodeficiency: a retrospective analysis of administration by infusion pump or subcutaneous rapid push
    Shapiro, R.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 173 (02) : 365 - 371
  • [40] Efficacy and Safety of Self-Administered Subcutaneous Immunoglobulin in Polish Children with Primary Immunodeficiency Diseases
    Stelmach, I.
    Bal, K.
    Sobocinska, A.
    Zaczeniuk, M.
    Podsiadlowicz-Borzecka, M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S304 - S304